# Bedrocan Internatioinal, Inc. — Form D

Bedrocan Internatioinal, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2010-02-09. The offering totals $400K, of which $200K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-02-09
- Form: D
- Accession: 0001483683-10-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $400K
- Amount sold: $200K
- Remaining: $200K
- Investors: 3
- Date of first sale: 2010-01-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-138595

## Issuer

- Name: Bedrocan Internatioinal, Inc.
- CIK: 0001483683
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 1209 ORANGE STREET, WILMINGTON, DE, 19801
- Phone: 510-528-5070

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Michael Sautman | Director | Kensington, CA |

## More

- [CIK 1483683 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1483683&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001483683-10-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.